Company Filing History:
Years Active: 2021-2022
Title: Janika Viereck: Innovator in Cardiac Research
Introduction
Janika Viereck is a prominent inventor based in Hannover, Germany. She has made significant contributions to the field of cardiac research, particularly in the development of therapeutic strategies for cardiac hypertrophy and remodeling. With a focus on long non-coding RNAs (lncRNAs), her work has the potential to impact the treatment of heart diseases.
Latest Patents
Janika Viereck holds 2 patents that showcase her innovative approach to cardiac therapy. Her latest patents include "LncRNAs for therapy and diagnosis of cardiac hypertrophy," which relates to a pharmaceutical composition that promotes or inhibits the expression of specific lncRNAs for treating cardiac hypertrophy. Another significant patent is "LNCRNA MEG3 for therapy and diagnosis of cardiac remodeling," which focuses on a compound that inhibits the expression of maternally expressed 3 (Meg3) to treat or prevent cardiac remodeling.
Career Highlights
Janika Viereck is affiliated with the Medizinische Hochschule Hannover, where she conducts her research and develops her inventions. Her work is characterized by a strong emphasis on the molecular mechanisms underlying cardiac conditions, contributing to advancements in therapeutic options.
Collaborations
Janika has collaborated with notable researchers in her field, including Thomas Thum and Maria-Teresa Piccoli. These collaborations have enhanced her research and expanded the impact of her inventions.
Conclusion
Janika Viereck is a trailblazer in cardiac research, with her patents paving the way for innovative therapies. Her contributions to the understanding and treatment of heart diseases highlight the importance of ongoing research in this critical area of health.